← Eichor
Study identifier: NCT04142307 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Biofeedback in Idiopathic Infantile Nystagmus Syndrome

Condition: Low Vision in Children  ·  Sponsor: Monica Daibert Nido

PhaseNA
Planned participants34
Who can joinAll sexes, 5 Years to 17 Years
Healthy volunteersNo

About this study

Active eye movement control training, an old and still most prevalent intervention in low vision rehabilitation (LVR) was never used in nystagmus clinically. Biofeedback training (BT) is the latest and newest technique for oculomotor control training in cases with low vision when using available modules in the new microperimetry instruments. Laboratory studies in the literature highlighted positive benefits from using BT in nystagmus cases. The purpose of this study is to assess systematically the impact of BT in a series of cases with Infantile Idiopathic Nystagmus (IIN) and formulate guidelines for further use of this intervention in nystagmus cases in general.

This description comes directly from the study's public registry record.

Talk to the study team

Monica Daibert-Nido, MD  ·  4164819995  ·  monica.nido@uhn.com

Samuel Markowitz, MD  ·  4164819995

Always discuss trial participation with your own doctor first.

Locations (1)

CNIBToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04142307